REFERENCES
- Dabernat H, Leophonte P, Bignon J, et al. Regional distribution of bacterial strains in acute exacerbations of bronchi-tis. Med Mal Infect 1994; 24: 21–28.
- Basran GS, Joseph J, Abbas AM, et al. Treatment of acute exacerbations of chronic airways disease — a comparison of amoxycillin and ciprofloxacin. J Antimicrob Chemother 1990; 26 ( Suppl F): 19-24.
- Castagno LA. Acute and chronic sinusitis. Evaluation and treatment. Folha Med 1994; 108 (5): 173–183.
- Farr BM, Mandell GL. Gram positive pneumonia. In: Pennington JE, ed. Respiratory infections: diagnosis and management, 2nd edition. New York: Raven Press, 298-313.
- Moller LV, Timens W, van der Bij W, Kooi K, de Weyer B, Dankert J, van Alphen L. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med 1998; 157 (3 Pt 1): 950-956.
- Cole P. Evaluating the clinical outcomes of respiratory infection. Int J Antimicrob Agents 1993; 3: S15—S19.
- Brown RB. Acute and chronic bronchitis. A practical management strategy. Postgrad Med 1989; 85: 249–254.
- Mathias AW Jr. Penicillins in the treatment of bacterial meningitis. J Roy Coll Physicians Lond 1972; 6: 139–146.
- Khan W, Ross S, Rodriguez W, Controni G, Saz AR. Haemophilus influenzae type B resistance to ampicillin: a report of two cases. JAMA 1974; 229: 298–301.
- Felmingham D. Antibiotic resistance. Do we need new therapeutic approaches? Chest 1995; 108 (Suppl 2): 70S-78S.
- Doern CV The Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-1993 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996; 38 ( Suppl A): 59-69.
- Grtineberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169–181.
- Medeiros AA, O'Brien TE. Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type enzyme but little permeability barrier to ampicillin. Lancet 1975; i: 716–719.
- Scriver SR, Walmsley SL, Kau CL, et al. Determination of antimicrobial susceptibility of Canadian isolates of Haemophilus influenzae and characterization of their ß-lacta-mases. Antimicrob Agents Chemother 1994; 38: 1678–1680.
- Kayser FH, Morenzoni G, Santanam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur Clin Microbiol Infect Dis 1990; 9: 810–817.
- Barry AL, Fuchs PC. Susceptibility of bacterial respiratory pathogens to amoxycillin and amoxycillin—clavulanic acid. Eur Clin Microbiol Infect Dis 1994; 13: 442–444.
- Bahal N, Nahata MC. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin and roxithromycin. Ann Pharmacother 1992; 26: 46–55.
- Kanatani MS, Guglielmo BJ. The new macrolides azithromycin and clarithromycin. West J Med 1994; 160: 31–37.
- Foulds G, Shepard RM, Johnson RB. The pharmacoki-netics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 ( Suppl A): 73-82.
- Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1–12.
- Craig WA. Antimicrobial resistance issues of the future. Diagn Microbiol Infect Dis 1996; 25: 213–217.
- Vogelman B, Gudmundsson S, Legget J, Turnidge J, Ebert S, Craig WA. Correlation of antimicrobial pharmacoki-netic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988; 158: 831–847.
- Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995; 22: 89–96.
- Craig WA, Andes D. Pharmacokinetics and pharmaco-dynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15: 255–259.
- Beghi GF, Berni F, Carratt L, et al. Efficacy and tolerability of azithromycin versus amoxycillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. J Chemother 1995; 7: 146–152.